CX3CL1 and Parkinson disease: A review of the different publications focused on the role of this chemokine in Parkinson’s disease (Table 2) suggests that CX3CL1 actions contribute to preventing the loss of neurons and the excessive activation of microglia that may also result in additional brain damage.